1. Home
  2. AVXL vs FCBC Comparison

AVXL vs FCBC Comparison

Compare AVXL & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • FCBC
  • Stock Information
  • Founded
  • AVXL 2004
  • FCBC 1874
  • Country
  • AVXL United States
  • FCBC United States
  • Employees
  • AVXL N/A
  • FCBC N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • FCBC Major Banks
  • Sector
  • AVXL Health Care
  • FCBC Finance
  • Exchange
  • AVXL Nasdaq
  • FCBC Nasdaq
  • Market Cap
  • AVXL 716.1M
  • FCBC 810.3M
  • IPO Year
  • AVXL N/A
  • FCBC 1992
  • Fundamental
  • Price
  • AVXL $9.24
  • FCBC $45.31
  • Analyst Decision
  • AVXL Strong Buy
  • FCBC Hold
  • Analyst Count
  • AVXL 2
  • FCBC 1
  • Target Price
  • AVXL $43.00
  • FCBC $38.00
  • AVG Volume (30 Days)
  • AVXL 1.4M
  • FCBC 32.8K
  • Earning Date
  • AVXL 02-05-2025
  • FCBC 01-21-2025
  • Dividend Yield
  • AVXL N/A
  • FCBC 2.72%
  • EPS Growth
  • AVXL N/A
  • FCBC N/A
  • EPS
  • AVXL N/A
  • FCBC 2.74
  • Revenue
  • AVXL N/A
  • FCBC $163,169,000.00
  • Revenue This Year
  • AVXL N/A
  • FCBC N/A
  • Revenue Next Year
  • AVXL N/A
  • FCBC N/A
  • P/E Ratio
  • AVXL N/A
  • FCBC $16.67
  • Revenue Growth
  • AVXL N/A
  • FCBC 7.32
  • 52 Week Low
  • AVXL $3.25
  • FCBC $31.00
  • 52 Week High
  • AVXL $10.45
  • FCBC $49.02
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 62.34
  • FCBC 49.64
  • Support Level
  • AVXL $7.93
  • FCBC $44.82
  • Resistance Level
  • AVXL $9.48
  • FCBC $46.12
  • Average True Range (ATR)
  • AVXL 0.65
  • FCBC 1.29
  • MACD
  • AVXL -0.01
  • FCBC -0.15
  • Stochastic Oscillator
  • AVXL 72.28
  • FCBC 38.78

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

Share on Social Networks: